Journal of Otolaryngology and Ophthalmology of Shandong University ›› 2021, Vol. 35 ›› Issue (6): 108-112.doi: 10.6040/j.issn.1673-3770.0.2020.493

Previous Articles     Next Articles

Treatment progress of endoscopic surgery for first diagnosed nasopharyngeal carcinoma

ZHOU Yuxiang1.2,MIAO Beiping1, LU Yongtian1   

  1. 1. Department of Otorhinolaryngology, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen 518035, Guangdong, China 2. Guangzhou Medical University, Guangzhou 510000, Guangdong, China
  • Published:2021-12-10

Abstract: Nasopharyngeal carcinoma(NPC)ranks first among head and neck tumors in terms of incidence. Radiotherapy is the first choice modality for treatment, although simultaneous chemotherapy, induced chemotherapy, molecular targeted therapy, surgery, and other comprehensive treatments are also feasible. With the development of endoscopic techniques and nasocranial base surgery in clinical practice, the early diagnosis and treatment of nasopharyngeal carcinoma have recently advanced. Head and neck surgeons have gradually applied the minimally invasive endoscopic surgery concept to the first diagnosis of nasopharyngeal carcinoma, with the purpose of improving the quality of life and survival rate of patients. In this paper, the status and progress of minimally invasive endoscopic surgery for the first nasopharyngeal carcinoma in recent years are reviewed.

Key words: Nasopharyngeal carcinoma, First option, Endoscopic, Operative treatment, New technique

CLC Number: 

  • R739.63
[1] 罗秀玲, 金风, 毕婷, 等. TPF方案诱导化疗不同给药方式联合调强放疗治疗局部晚期鼻咽癌的中期疗效及预后分析[J]. 中华放射医学与防护杂志, 2018, 38(8): 595-601. doi:10.3760/cma.j.issn.0254-5098.2018.08.007. LUO Xiuling, JIN Feng, BI Ting, et al. Mid-term efficacy and prognosis of TPF regimen induction chemotherapy combined with IMRT for locally advanced nasopharyngeal carcinoma[J]. Chin J Radiol Med Prot, 2018, 38(8): 595-601. doi:10.3760/cma.j.issn.0254-5098.2018.08.007.
[2] 余洪猛, 孙希才, 宋小乐. 复发性鼻咽癌内镜手术治疗现状[J]. 中国现代神经疾病杂志, 2019, 19(4): 226-231. doi:10.3969/j.issn.1672-6731.2019.04.003. YU Hongmeng, SUN Xicai, SONG Xiaole. Current situation of endoscopic surgery for recurrent nasopharyngeal carcinoma[J]. Chin J Contemp Neurol Neurosurg, 2019, 19(4): 226-231. doi:10.3969/j.issn.1672-6731.2019.04.003.
[3] King WWK, Ku PKM, Mok CO, et al. Nasopharyngectomy in the treatment of recurrent nasopharyngeal carcinoma: a twelve-year experience[J]. Head Neck, 2000, 22(3): 215-222. doi:10.1002/(sici)1097-0347(200005)22: 3<215: aid-hed2>3.0.co;2-b.
[4] 邱前辉, 李娜, 张秋航, 等. 内镜手术治疗首诊局部晚期鼻咽癌的疗效分析[J]. 中华耳鼻咽喉头颈外科杂志, 2017, 52(5): 365-371. doi:10.3760/cma.j.issn.1673-0860.2017.05.009. QIU Qianhui, LI Na, ZHANG Qiuhang, et al. Clinical efficacy of endoscopic nasopharyngectomy for initially diagnosed advanced nasopharyngeal carcinoma[J]. Chin J Otorhinolaryngol Head Neck Surg, 2017, 52(5): 365-371. doi:10.3760/cma.j.issn.1673-0860.2017.05.009.
[5] 王剑祁, 李刚, 韩日, 等. 局部复发性鼻咽癌挽救性手术治疗[J]. 临床耳鼻咽喉头颈外科杂志, 2016,30(22): 1823-1826. doi:10.13201/j.issn.1001-1781.2016.22.023. WANG Jianqi, LI Gang, HAN Ri, et al. Salvage surgical treatment for local recurrent nasopharyngeal cancer[J]. J Clin Otorhinolaryngol Head Neck Surg, 2016,30(22): 1823-1826. doi:10.13201/j.issn.1001-1781.2016.22.023.
[6] 吴双, 郎锦义, 李志琳, 等. 复发性鼻咽癌再次放疗182例临床分析[J]. 四川医学, 2000, 21(3): 199-201. doi:10.16252/j.cnki.issn1004-0501-2000.03.006. WU Shuang, LANG Jinyi, LI Zhilin, et al. Re-irradiation of recurrent nasopharyngeal carcinoma[J]. Sichuan Med J, 2000, 21(3): 199-201. doi:10.16252/j.cnki.issn1004-0501-2000.03.006.
[7] Lee AW, Law SC, Foo W, et al. Retrospective analysis of patients with nasopharyngeal carcinoma treated during 1976-1985: survival after local recurrence[J]. Int J Radiat Oncol Biol Phys, 1993, 26(5): 773-782. doi:10.1016/0360-3016(93)90491-d.
[8] Yoshizaki T, Wakisaka N, Murono S, et al. Endoscopic nasopharyngectomy for patients with recurrent nasopharyngeal carcinoma at the primary site[J]. Laryngoscope, 2005, 115(8): 1517-1519. doi:10.1097/01.MLG.0000165383.35100.17.
[9] You R, Zou X, Hua YJ, et al. Salvage endoscopic nasopharyngectomy is superior to intensity-modulated radiation therapy for local recurrence of selected T1-T3 nasopharyngeal carcinoma-A case-matched comparison[J]. Radiother Oncol, 2015, 115(3): 399-406. doi:10.1016/j.radonc.2015.04.024.
[10] Simo R, Robinson M, Lei M, et al. Nasopharyngeal carcinoma: united kingdom national multidisciplinary guidelines[J]. J Laryngol Otol, 2016, 130(S2): S97-S103. doi:10.1017/S0022215116000517.
[11] 中国抗癌协会鼻咽癌专业委员会,林少俊,陈晓钟, 等.复发鼻咽癌治疗专家共识[J].中华放射肿瘤学志, 2018, 27(1): 16-22. doi:10.3760/cma.j.issn.1004-4221.2018.01.004. nasopharyngeal carcinoma[J]. Laryngoscope, 2007, 117(5): 894-896. doi:10.1097/MLG.0b013e3180381644.
[12] 刘全, 孙希才, 于华鹏, 等. 鼻内镜下鼻咽癌切除术的手术分型[J]. 山东大学耳鼻喉眼学报, 2019, 33(2): 39-45. doi: 10.6040/j.issn.1673-3770.1.2019.016. LIU Quan, SUN Xicai, YU Huapeng, et al. Types of endoscopic transnasal nasopharyngectomy for nasopharyngeal carcinoma[J]. J Otolaryngol Ophthalmol Shandong Univ, 2019, 33(2): 39-45. doi: 10.6040/j.issn.1673-3770.1.2019.016.
[13] Liu J, Yu HP, Sun XC, et al. Salvage endoscopic nasopharyngectomy for local recurrent or residual nasopharyngeal carcinoma: a 10-year experience[J]. Int J Clin Oncol, 2017, 22(5):834-842. doi: 10.1007/s10147-017-1143-9.
[14] Chan KCA, Woo JKS, King A, et al. Analysis of plasma Epstein-Barr virus DNA to screen for nasopharyngeal cancer[J]. N Engl J Med, 2017, 377(6): 513-522. doi:10.1056/nejmoa1701717.
[15] Ji MF, Huang QH, Yu X, et al. Evaluation of plasma epstein-barr virus DNA load to distinguish nasopharyngeal carcinoma patients from healthy high-risk populations in Southern China[J]. Cancer, 2014, 120(9): 1353-1360. doi:10.1002/cncr.28564.
[16] Zhang MX, Li J, Shen GP, et al. Intensity-modulated radiotherapy prolongs the survival of patients with nasopharyngeal carcinoma compared with conventional two-dimensional radiotherapy: A 10-year experience with a large cohort and long follow-up[J]. Eur J Cancer, 2015, 51(17): 2587-95. doi: 10.1016/j.ejca.2015.08.006.
[17] Su SF, Han F, Zhao C, et al. Long-term outcomes of early-stage nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy alone[J]. Int J Radiat Oncol Biol Phys,2012,82(1):327-33. doi: 10.1016/j.ijrobp.2010.09.011.
[18] 司勇锋, 陶仲强, 张政, 等. 手术联合同步放化疗治疗早期鼻咽癌的前瞻性研究[J]. 临床耳鼻咽喉头颈外科杂志, 2012, 26(9): 422-425. doi: 10.3969/j.issn.1672-5085.2012.48.323. SI Yongfeng, TAO Zhongqiang, ZHANG Zheng, et al. A prospective study of surgery combined with concurrent radiochemotherapy in the treatment of patients with early stage nasopharyngeal carcinoma[J]. Journal of Clinical Otorhinolaryngology, 2012, 26(9): 422-425. doi: 10.3969/j.issn.1672-5085.2012.48.323.
[19] Liu YP, Xie YL, Zou X, et al. Techniques of endoscopic nasopharyngectomy for localized stage I nasopharyngeal carcinoma[J]. Head Neck, 2020, 42(4): 807-812. doi:10.1002/hed.26090.
[20] Liu YP, Lv X, Zou X, et al. Minimally invasive surgery alone compared with intensity-modulated radiotherapy for primary stage I nasopharyngeal carcinoma[J]. Cancer Commun(Lond), 2019, 39(1): 75. doi:10.1186/s40880-019-0415-3.
[21] 赵丽娟, 姜彦, 于龙刚, 等. 鼻咽癌内镜手术治疗临床分析[J]. 山东大学耳鼻喉眼学报, 2019, 33(2): 51-56. doi:10.6040/j.issn.1673-3770.0.2019.073. ZHAO Lijuan, JIANG Yan, YU Longgang, et al. Clinical analysis of endoscopic surgery for nasopharyngeal carcinoma[J]. J Otolaryngol Ophthalmol Shandong Univ, 2019, 33(2): 51-56. doi:10.6040/j.issn.1673-3770.0.2019.073.
[22] Weng JJ, Wei JZ, Li M, et al. Effects of surgery combined with chemoradiotherapy on short- and long-term outcomes of early-stage nasopharyngeal carcinoma[J]. Cancer Manag Res, 2020, 12: 7813-7826. doi:10.2147/CMAR.S262567.
[23] Huang Y, Qiu QH. Endoscopic surgery for early-stage nasopharyngeal carcinoma: a justified initial option[J]. Acta Otolaryngol, 2017, 137(11): 1194-1198. doi:10.1080/00016489.2017.1351041.
[24] Lee CC, Huang TT, Lee MS, et al. Clinical application of tumor volume in advanced nasopharyngeal carcinoma to predict outcome[J]. Radiat Oncol, 2010, 5: 20. doi:10.1186/1748-717x-5-20.
[25] Wu Z, Su Y, Zeng RF, et al. Prognostic value of tumor volume for patients with nasopharyngeal carcinoma treated with concurrent chemotherapy and intensity-modulated radiotherapy[J]. J Cancer Res Clin Oncol, 2014, 140(1): 69-76. doi:10.1007/s00432-013-1542-x.
[26] 邱前辉, 陈卓. 鼻内镜手术治疗首诊局部晚期鼻咽癌及放疗后严重并发症的作用[J]. 山东大学耳鼻喉眼学报, 2019, 33(2): 17-20. doi:10.6040/j.issn.1673-3771.1.2019.012. QIU Qianhui, CHEN Zhuo. Endoscopic surgery for the treatment of locally advanced nasopharyngeal carcinoma and serious complications after radio-therapy[J]. J Otolaryngol Ophthalmol Shandong Univ, 2019, 33(2): 17-20. doi:10.6040/j.issn.1673-3771.1.2019.012.
[27] 邱前辉, 高俊潇. 鼻咽癌外科治疗的历史与现状及展望[J]. 中国耳鼻咽喉颅底外科杂志, 2020, 26(5): 473-477. doi:10.11798/j.issn.1007-1520.202005001. QIU Qianhui, GAO Junxiao. The history, current situation and prospect of surgery of nasopharyngeal carcinoma[J]. Chin J Otorhinolaryngol - Skull Base Surg, 2020, 26(5): 473-477. doi:10.11798/j.issn.1007-1520.202005001.
[28] Ozer E, Waltonen J. Transoral robotic nasopharyngectomy: a novel approach for nasopharyngeal lesions[J]. Laryngoscope, 2008, 118(9): 1613-1616. doi:10.1097/MLG.0b013e3181792490.
[29] Wei WI, Ho WK. Transoral robotic resection of recurrent nasopharyngeal carcinoma[J]. Laryngoscope, 2010, 120(10): 2011-2014. doi:10.1002/lary.21059.
[30] Tsang RK, To VS, Ho AC, et al. Early results of robotic assisted nasopharyngectomy for recurrent nasopharyngeal carcinoma[J]. Head Neck, 2015, 37(6): 788-793. doi:10.1002/hed.23672.
[31] Chan JYW, Wei WI. Three-dimensional endoscopy for endoscopic salvage nasopharyngectomy: Preliminary report of experience[J]. Laryngoscope, 2018, 128(6): 1386-1391. doi:10.1002/lary.26993.
[1] ZHANG Guomin, WANG Maohua, GAO Song, WU Wenbin, YU Youjun. Analysis of the surgical efficacy of adhesive otitis media under continuous irrigating mode for endoscopic ear surgery [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(3): 16-19.
[2] LIN Xiaoxue, LIN Baorui, LI Peishan, LU Biaoqing. Application of electronic nasopharyngoscopy combined with narrow band imaging in traditional Chinese medicine syndrome differentiation of nasopharyngeal carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(3): 40-46.
[3] ZHU Jiang, LIU Taixiang, JIANG Bing. Changes in conjunctival sac microbiota before and after endoscopic dacryocystorhinostomy [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(1): 13-20.
[4] LU Zhaoyang, ZHAI Zhaoxue, WANG Huikang, SHAO Liting, ZHANG Yu. COVID-19 treatment-induced diabetic ketoacidosis combined with rhino-orbital cerebral mucormycosis: a case report and literature review [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(1): 90-94.
[5] LI Shuai, HUANG Chunyan, CHANG Mingzhang. Endoscopic correction of caudal septal cartilage deviation:clinical outcome analysis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(6): 65-70.
[6] WANG Sheng, LI Yindan, YANG Jinji. The role of microRNA in nasopharyngeal carcinoma and its research progress [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(5): 125-131.
[7] QIU Qianhui, XIAO Xuping, YANG Qintai, YE Jing, DENG Zeyi, WANG Desheng, TAN Guolin, JIANG weihong,. Expert consensus on clinical management recommendations for carotid blowout syndrome secondary to NPC treatment [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 1-18.
[8] WANG Siquan, ZHU Hongshen, ZHANG Xiaobin, ZHAO Zhouyang, MA Yue, YANG Yimei, HUANG Lijin. Analysis of factors associated with stroke and cranial nerve palsy after unilateral internal carotid artery embolization in patients with nasopharyngeal carcinoma after radiotherapy [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 19-25.
[9] HUANG Qiao, REN Yi, HOU Tao, LIAO Xingwei, ZHU Zi’ang, ZHAN Xiaolin, LIU Ying, YIN Shihua. Expression of EphB2 in nasopharyngeal carcinoma tissues and its correlation with clinicopathological characteristics [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 26-30.
[10] SUN Chunxiao, WANG Wenqing, YUE Tian, LIU Jisheng. Efficacy analysis of concurrent chemoradiotherapy with high and low cumulative cisplatin doses in the treatment of nasopharyngeal carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 31-41.
[11] WANG Zaixing, TANG Zhiyuan, LI Dingbo, SHI Zhaohui, ZENG Xianhai, ZHANG Qiuhang. Treatment of internal carotid artery rupture caused by tumor recurrence and skull base osteonecrosis after radiotherapy for nasopharyngeal carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 49-58.
[12] SUN Fang, XIE Chubo, QIU Qianhui. Retrospective analysis of nutritional indexes and their impact on wound healing in patients with radiation-induced skull base osteoradionecrosis after treatment with nasopharyngeal carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 59-68.
[13] JIANG Zhilin, ZHU Ruikai, QIU Qianhui. Imaging-based observation and analysis of the pharyngeal internal carotid artery trajectory [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 69-76.
[14] ZHU Ruikai, WU Jiarong, SUN Fang, XIE Chubo, QIU Qianhui. Computed tomography angiography-based assessment of internal carotid artery stenosis after radiotherapy for nasopharyngeal carcinoma and its associated factors [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 77-84.
[15] QIN Debo, XUE Jiancheng, YANG Wenyue, HU Bing, CHEN Tao, YU Yanping, MENG Qingguo, SUN Huanji, MIAO Beiping, LU Yongtian. Changing the diagnosis and treatment of nasopharyngeal cancer: biomarkers and nasal endoscopic surgery synergise to advance early treatment development [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 85-92.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!